Rasburicase Treatment for Chemotherapy or Malignancy-Induced Hyperuricemia in Asthma/Allergy Patients

Completed

Conditions studied: Leukemia, Lymphoma, Tumor Lysis Syndrome, Hyperuricemia

In brief

This is a multi-center trial for rasburicase in children at high risk of tumor lysis syndrome who have a history of asthma/atopy. The main purpose of this study is to establish the safety of this drug in patients with a history of asthma or severe allergies.

Key facts

Study ID
NCT00186940
Run by
St. Jude Children's Research Hospital
People needed
16
Starts
2005-03-01
Expected to finish
2010-02-01
Last updated by the study team
2017-04-25

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.